VECTORMUNE® FP-LT is a genetically engineered, live Fowl Pox virus vaccine for use in chickens. The Fowl Pox virus has been genetically modified to express key protective Laryngotracheitis (LT) virus antigens. This vaccine is presented in a freeze-dried preparation.
VECTORMUNE® FP-LT is a genetically engineered live fowl pox virus vaccine carrying 2 immunorelevant genes from LT virus.
The following illustration shows the insertion of 2 LT virus genes into the Fowl Pox viral genome resulting in a live Fowl Pox virus vectored LT contained in VECTORMUNE® FP-LT vaccine.
VECTORMUNE® FP-LT is recommended for wing web application to healthy, susceptible chickens eight weeks of age or older, but at least four weeks prior to the onset of egg production. VECTORMUNE® FP-LT is indicated as an aid in the prevention of Fowl Pox and Infectious Laryngotracheitis. Chickens receiving this vaccine must not have been previously exposed to field Fowl Pox virus or pox vaccine due to interference with immunity following vaccination.